RECRUITING

Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

Description

The Division of Kidney, Urologic, and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Heart, Lung and Blood Institute (NHLBI) funded a cooperative agreement including two Clinical Coordinating Centers (at Children's Hospital of Philadelphia and at Children's Mercy Hospital in Kansas City), a central biochemistry laboratory (at the University of Minnesota) and a Data Coordinating Center (at Johns Hopkins School of Public Health) to conduct a prospective epidemiological study of children with chronic kidney disease (CKD).

Study Overview

Study Details

Study overview

The Division of Kidney, Urologic, and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Heart, Lung and Blood Institute (NHLBI) funded a cooperative agreement including two Clinical Coordinating Centers (at Children's Hospital of Philadelphia and at Children's Mercy Hospital in Kansas City), a central biochemistry laboratory (at the University of Minnesota) and a Data Coordinating Center (at Johns Hopkins School of Public Health) to conduct a prospective epidemiological study of children with chronic kidney disease (CKD).

Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

Condition
Chronic Kidney Disease
Intervention / Treatment

-

Contacts and Locations

Kansas City

Children's Mercy Kansas City, Kansas City, Missouri, United States, 64108

Philadelphia

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States, 19146

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age between 1 and 16 years (before 17th birthday) for Cohorts 1 and 2; age between 6 months and 16 years (before 17th birthday) for Cohort 3; age between 16 to 22 years (before 23rd birthday) for Cohort 4 and regularly seen by pediatric nephrologist prior to enrollment
  • * Estimated (based on SCr) Schwartz GFR between 30 and 90 ml/min\|1.73m2 for Cohort 1 OR an estimated GFR between 45 and 90 ml/min\|1.73m2 based on the updated Schwartz formula for Cohort 2; an estimated GFR ≤60 based on the CKiD Under 25 estimating equation (U25eGFR) OR KRT experience (dialysis or transplant) for Cohort 4
  • * Willingness and ability to provide informed consent and assent
  • * For Cohort 3, children with non-glomerular diagnosis and duration of kidney disease less than 5 years will be enrolled.
  • * Solid organ (other than kidney), bone marrow or stem cell transplantation
  • * Cancer diagnosis and receiving treatment or within 12 months post completion of treatment
  • * HIV diagnosis and receiving treatment or within 12 months post completion of treatment
  • * Current pregnancy or pregnancy within past twelve months
  • * Inability to complete major data collection procedures
  • * Not fluent in English or Spanish
  • * Plans to move out of area of any participating CKiD site (families can be transferred to another CKiD site if the family moves)
  • * Existing moderate to severe congenital structural heart disease
  • * Genetic syndromes involving the central nervous system (e.g., Downs syndrome)
  • * History of severe to profound intellectual disability (i.e., Intelligence Quotient (IQ)\<40, significant impairment in adaptive function and/or inability to independently execute self-care skills)
  • * For cohort 3, children who are expected to receive renal replacement therapy within 6 months of date of enrollment will not be recruited

Ages Eligible for Study

6 Months to 22 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Johns Hopkins Bloomberg School of Public Health,

Susan Furth, MD, PhD, PRINCIPAL_INVESTIGATOR, Children's Hospital of Philadelphia

Bradley Warady, MD, PRINCIPAL_INVESTIGATOR, Children's Mercy Kansas City

George Schwartz, MD, PRINCIPAL_INVESTIGATOR, University of Rochester

Derek Ng, PhD, PRINCIPAL_INVESTIGATOR, Johns Hopkins Bloomberg School of Public Health

Jesse Seegmiller, PhD, PRINCIPAL_INVESTIGATOR, University of Minnesota

Study Record Dates

2028-07